Litchfield Caroline

EVP & CFO

Litchfield Caroline has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: May 1, 2026.

On the most recent filing, Litchfield Caroline is listed as EVP & CFO at Merck & Co., Inc. Inside the rolling window, Litchfield Caroline reported no open-market purchases and 1 open-market sale totaling $5.0M in MRK.

Companies traded

Other insiders at MRK

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$5.0M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MRKSale$5.0MFeb 6SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Litchfield Caroline made?

Litchfield Caroline has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.

Which companies does Litchfield Caroline trade?

Litchfield Caroline has filed SEC Form 4 disclosures for 1 company, including MRK.

When was Litchfield Caroline's most recent SEC Form 4 filing?

Litchfield Caroline's most recent SEC Form 4 filing on Tracefour is dated May 1, 2026.

What is Litchfield Caroline's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Litchfield Caroline is listed as EVP & CFO.

What is Litchfield Caroline's total buy and sell value in the current window?

Inside the rolling retention window, Litchfield Caroline bought $0 and sold $5.0M based on SEC Form 4 filings.

What was Litchfield Caroline's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 41,997 MRK shares on 2026-02-04, worth $5.0M, per SEC Form 4 filings.